NDC Compounded Drug 51754-9131-5 Midazolam Hydrochloride
Injection Intravenous

Compounded Drug Product Information

NDC Product Code 51754-9131
NDC Package Code 51754-9131-5
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
51754913105
Package Description 100 mL in 1 VIAL, GLASS
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Midazolam Hcl In 0.8% Sodium Chloride 100 Mg/100 Ml
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Midazolam Hcl 100 Mg/100 Ml
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
Midazolam Hydrochloride
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 51754
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Exela Pharma Sciences, Llc.
Substance Name Midazolam Hydrochloride
Active Ingredients Information 100 mg/100 mL
DEA Schedule What is the Drug Enforcement Administration (DEA) CIV Schedule?
The controlled substances in the CIV schedule have an abuse potential and dependence liability less than those listed in CIII and have an accepted medical use in the United States.
Schedule IV (CIV) Substances
Reporting Period 2021-2

Frequently Asked Questions

What is the NDC number assigned to Midazolam Hcl In 0.8% Sodium Chloride 100 Mg/100 Ml?

Midazolam Hcl In 0.8% Sodium Chloride 100 Mg/100 Ml was assigned by its manufacturer with NDC product code 51754-9131. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Midazolam Hcl In 0.8% Sodium Chloride 100 Mg/100 Ml?

The NDC package code 51754-9131-5 was assigned to a 100 mL in 1 VIAL, GLASS of midazolam hydrochloride administered intravenous via injection.

Who manufactures this product?

Midazolam Hcl In 0.8% Sodium Chloride 100 Mg/100 Ml is manufactured by an outsourced facility and labeled by Exela Pharma Sciences, Llc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.